Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × BEBT-908 × Clear all

NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

Lymphoma, Large B-Cell, Diffuse